Veeva Systems (VEE) Stock Forecast & Price Target

13 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

VEE Analyst Ratings

Moderate Buy

17 Buy

6 Hold

1 Sell

Based on 24 analysts giving stock ratings to

Veeva

Systems

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

VEE Stock 12 Month Forecast

Average Price Target

€255.69

▲(21.01% Upside)

Based on 24 Wall Street analysts offering 12 month price targets for Veeva Systems in the last 3 months. The average price target is €255.69 with a high forecast of €296.12 and a low forecast of €156.77. The average price target represents a 21.01% change from the last price of €211.30.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"131":"€131","214":"€214","297":"€297","172.5":"€172.5","255.5":"€255.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":296.122881,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€296.12</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":255.68593296428566,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€255.69</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":156.770937,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€156.77</span>\n  </div></div>","useHTML":true}}],"tickPositions":[131,172.5,214,255.5,297],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,243.5,247.54791392307692,251.59582784615384,255.64374176923076,259.6916556923077,263.7395696153846,267.7874835384615,271.8353974615385,275.8833113846154,279.93122530769233,283.97913923076925,288.02705315384617,292.0749670769231,{"y":296.122881,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,243.5,244.4373794587912,245.3747589175824,246.3121383763736,247.24951783516482,248.186897293956,249.12427675274722,250.06165621153843,250.99903567032965,251.93641512912083,252.87379458791204,253.81117404670326,254.74855350549444,{"y":255.68593296428566,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,243.5,236.82853361538463,230.15706723076923,223.48560084615386,216.81413446153846,210.1426680769231,203.4712016923077,196.79973530769232,190.12826892307692,183.45680253846155,176.78533615384617,170.11386976923077,163.44240338461537,{"y":156.770937,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":230,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":246.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":251.4,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":208.3,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":192.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172.2,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.15,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.35,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.3,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":164,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":161.35,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.6,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.5,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€296.12

Average Price Target€255.69

Lowest Price Target€156.77

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Craig Hettenbach

Morgan Stanley

€239.51

Hold

13.35%

Upside

Assigned

09/18/26

Veeva Systems (VEEV) Gets a Hold from Morgan Stanley

Unknown Analyst

CFRA

Not Ranked

CFRA

―

Buy

―

Upgraded

09/16/26

CFRA upgrades Veeva Systems (VEEV) to a Buy

Charles Rhyee

TD Cowen

€246.48

Buy

16.65%

Upside

Reiterated

09/15/26

Analysts Conflicted on These Healthcare Names: Veeva Systems (NYSE: VEEV), Mereo Biopharma Group Plc (NASDAQ: MREO) and Tvardi Therapeutics (NASDAQ: TVRD)

Stan Berenshteyn

Wells Fargo

€287.41

Buy

36.02%

Upside

Assigned

09/09/26

AI-Driven Upside Spurs Stan Berenshteyn to Reiterate Buy on Veeva and Raise Price Target from $320 to $330

Alexei Gogolev

J.P. Morgan

€260.41

Buy

23.24%

Upside

Reiterated

09/01/26

Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Kodiak Sciences (NASDAQ: KOD)

Karl Keirstead

UBS

€165.48→€252.58

Hold

19.53%

Upside

Assigned

08/28/26

Veeva price target raised to $290 from $190 at UBSVeeva price target raised to $290 from $190 at UBS

Tyler Radke

Citi

€165.48→€237.77

Hold

12.53%

Upside

Reiterated

08/28/26

Veeva price target raised to $273 from $190 at CitiVeeva price target raised to $273 from $190 at Citi

Saket Kalia

Barclays

€239.51→€274.35

Buy

29.84%

Upside

Reiterated

08/27/26

Barclays Keeps Their Buy Rating on Veeva Systems (VEEV)

Kirk Materne

Evercore ISI

€161.13→€217.74

Hold

3.05%

Upside

Reiterated

08/27/26

Veeva price target raised to $250 from $185 at Evercore ISIVeeva price target raised to $250 from $185 at Evercore ISI

Joseph Vruwink

Robert W. Baird

€226.45→€261.28

Buy

23.66%

Upside

Reiterated

08/27/26

Veeva price target raised to $300 from $260 at BairdVeeva price target raised to $300 from $260 at Baird

Kenneth Wong

Oppenheimer

€261.28→€283.06

Buy

33.96%

Upside

Reiterated

08/27/26

Oppenheimer Keeps Their Buy Rating on Veeva Systems (VEEV)

Brian Peterson

Raymond James

€195.96→€287.41

Buy

36.02%

Upside

Reiterated

08/27/26

Veeva price target raised to $330 from $225 at Raymond JamesVeeva price target raised to $330 from $225 at Raymond James

David Grossman

Stifel Nicolaus

€239.51→€261.28

Buy

23.66%

Upside

Reiterated

08/27/26

Veeva Systems (VEEV) Receives a Buy from Stifel Nicolaus

Dylan Becker

William Blair

―

Buy

―

Reiterated

08/27/26

Veeva Gets Buy Rating as Revenue Reaccelerates, Guidance Rises and AI-Driven Life Sciences Moat Widens

Billy Fitzsimmons

Piper Sandler

€256.93→€278.7

Buy

31.90%

Upside

Reiterated

08/27/26

Veeva price target raised to $320 from $295 at Piper SandlerVeeva price target raised to $320 from $295 at Piper Sandler

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Craig Hettenbach

Morgan Stanley

€239.51

Hold

13.35%

Upside

Assigned

09/18/26

Veeva Systems (VEEV) Gets a Hold from Morgan Stanley

Unknown Analyst

CFRA

Not Ranked

CFRA

―

Buy

―

Upgraded

09/16/26

CFRA upgrades Veeva Systems (VEEV) to a Buy

Charles Rhyee

TD Cowen

€246.48

Buy

16.65%

Upside

Reiterated

09/15/26

Analysts Conflicted on These Healthcare Names: Veeva Systems (NYSE: VEEV), Mereo Biopharma Group Plc (NASDAQ: MREO) and Tvardi Therapeutics (NASDAQ: TVRD)

Stan Berenshteyn

Wells Fargo

€287.41

Buy

36.02%

Upside

Assigned

09/09/26

AI-Driven Upside Spurs Stan Berenshteyn to Reiterate Buy on Veeva and Raise Price Target from $320 to $330

Alexei Gogolev

J.P. Morgan

€260.41

Buy

23.24%

Upside

Reiterated

09/01/26

Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Kodiak Sciences (NASDAQ: KOD)

Karl Keirstead

UBS

€165.48→€252.58

Hold

19.53%

Upside

Assigned

08/28/26

Veeva price target raised to $290 from $190 at UBSVeeva price target raised to $290 from $190 at UBS

Tyler Radke

Citi

€165.48→€237.77

Hold

12.53%

Upside

Reiterated

08/28/26

Veeva price target raised to $273 from $190 at CitiVeeva price target raised to $273 from $190 at Citi

Saket Kalia

Barclays

€239.51→€274.35

Buy

29.84%

Upside

Reiterated

08/27/26

Barclays Keeps Their Buy Rating on Veeva Systems (VEEV)

Kirk Materne

Evercore ISI

€161.13→€217.74

Hold

3.05%

Upside

Reiterated

08/27/26

Veeva price target raised to $250 from $185 at Evercore ISIVeeva price target raised to $250 from $185 at Evercore ISI

Joseph Vruwink

Robert W. Baird

€226.45→€261.28

Buy

23.66%

Upside

Reiterated

08/27/26

Veeva price target raised to $300 from $260 at BairdVeeva price target raised to $300 from $260 at Baird

Kenneth Wong

Oppenheimer

€261.28→€283.06

Buy

33.96%

Upside

Reiterated

08/27/26

Oppenheimer Keeps Their Buy Rating on Veeva Systems (VEEV)

Brian Peterson

Raymond James

€195.96→€287.41

Buy

36.02%

Upside

Reiterated

08/27/26

Veeva price target raised to $330 from $225 at Raymond JamesVeeva price target raised to $330 from $225 at Raymond James

David Grossman

Stifel Nicolaus

€239.51→€261.28

Buy

23.66%

Upside

Reiterated

08/27/26

Veeva Systems (VEEV) Receives a Buy from Stifel Nicolaus

Dylan Becker

William Blair

―

Buy

―

Reiterated

08/27/26

Veeva Gets Buy Rating as Revenue Reaccelerates, Guidance Rises and AI-Driven Life Sciences Moat Widens

Billy Fitzsimmons

Piper Sandler

€256.93→€278.7

Buy

31.90%

Upside

Reiterated

08/27/26

Veeva price target raised to $320 from $295 at Piper SandlerVeeva price target raised to $320 from $295 at Piper Sandler

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ZVRAZevra Therapeutics

ELVNEnliven Therapeutics

DFTXDefinium Therapeutics

AMRXAmneal Pharmaceuticals

DNTHDianthus Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Veeva Systems

3 Months

Stan BerenshteynWells Fargo

Success Rate

17/25 ratings generated profit

Average Return

+8.70%

Copying Stan Berenshteyn's trades and holding each position for 3 Months would result in 68.00% of your transactions generating a profit, with an average return of +8.70% per trade.

1 Year

Kenneth WongOppenheimer

Success Rate

34/49 ratings generated profit

Average Return

+19.16%

Copying Kenneth Wong's trades and holding each position for 1 Year would result in 69.39% of your transactions generating a profit, with an average return of +19.16% per trade.

2 Years

Rishi JaluriaRBC Capital

Success Rate

18/24 ratings generated profit

Average Return

+20.08%

Copying Rishi Jaluria's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +20.08% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VEE Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, VEE has received 35 Buy Ratings, 7 Hold Ratings, and 1 Sell Ratings. VEE average Analyst price target in the past 3 months is 255.69.

Each month's total comprises the sum of three months' worth of ratings.

VEE Financial Forecast

VEE Earnings Forecast

Next quarter’s earnings estimate for VEE is €2.04 with a range of €2.02 to €2.09. The previous quarter’s EPS was €2.05. VEE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year VEE has Performed in-line its overall industry.

VEE Sales Forecast

Next quarter’s sales forecast for VEE is €814.02M with a range of €811.74M to €822.80M. The previous quarter’s sales results were €807.89M. VEE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year VEE has Performed in-line its overall industry.

VEE Stock Forecast FAQ

What is DE:VEE’s average 12-month price target, according to analysts?

Based on analyst ratings, Veeva Systems’s 12-month average price target is 255.69.

What is DE:VEE’s upside potential, based on the analysts’ average price target?

Veeva Systems has 21.01% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Veeva Systems a Buy, Sell or Hold?

Veeva Systems has a consensus rating of Moderate Buy, which is based on 17 buy ratings, 6 hold ratings and 1 sell ratings.

What is Veeva Systems’s share price target?

The average share price target for Veeva Systems is 255.69. This is based on 24 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €296.12 ,and the lowest forecast is €156.77. The average share price target represents 21.01% Increase from the current price of €211.3.

What do analysts say about Veeva Systems?

Veeva Systems’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 24 Wall Streets Analysts.

How can I buy shares of Veeva Systems?

To buy shares of DE:VEE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Veeva Systems (VEE) Stock Forecast & Price Target

VEE Analyst Ratings

VEE Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Veeva Systems

VEE Analyst Recommendation Trends

VEE Financial Forecast

VEE Earnings Forecast

VEE Sales Forecast

VEE Stock Forecast FAQ

Detailed List of Analyst Forecasts